Ethnic representation was a strength of the study; 43% of participants identified as Hispanic/Latino, Asian, Black/African American, or as multiracial. Additionally, feasibility performance was ...

Capsida Biotherapeutics ("Capsida") today announced new preclinical data for CAP-004, a potential best-in-class systemically ...